Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET

DALLAS--(BUSINESS WIRE)--Mar 11, 2024--

Related Keywords

Texas ,United States , ,Nasdaq ,Lantern Pharma Inc ,Exchange Commission On ,Securities Exchange ,Linkedin ,Panna Sharma ,Chief Executive Officer ,Lantern Pharma ,Starlight Therapeutics ,Looking Statements ,Securities Act ,Securities Exchange Act ,Risk Factors ,Annual Report ,Exchange Commission ,Investor Relations Contact ,Business Wire ,